XML 44 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock award plan (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of stock option activity
A summary of stock option activity is as follows:
 
 
Number of
options
 
Weighted-
average
exercise
price
 
Weighted-
average
remaining
contractual
term
 
Aggregate
intrinsic
value
 
 
 
 
 
 
 
 
(in
thousands)
Outstanding at December 31, 2017
 
6,448,642

 
$
29.00

 
 
 
 

Granted
 
2,914,139

 
$
25.84

 
 
 
 

Exercised
 
512,145

 
$
17.03

 
 
 
 

Forfeited/Cancelled
 
(329,404
)
 
$
34.20

 
 
 
 

Outstanding at September 30, 2018
 
9,545,522

 
$
28.44

 
7.45 years
 
$
172,859

Vested or Expected to vest at September 30, 2018
 
3,914,413

 
$
24.38

 
8.93 years
 
$
89,547

Exercisable at September 30, 2018
 
4,316,071

 
$
32.33

 
5.99 years
 
$
77,003

Schedule of assumptions used to estimate fair values of grants made on the date of grant
The fair value of grants made in the nine months ended September 30, 2018 was contemporaneously estimated on the date of grant using the following assumptions:
 
 
Nine months ended
September 30, 2018
Risk-free interest rate
 
2.25%—3.03%
Expected volatility
 
64%—90%
Expected term
 
5.04 – 10.00 years
Summary of information on the Company's restricted stock
The following table summarizes information on the Company’s restricted stock awards and units:
 
 
Restricted Stock Awards and Units
 
 
Number of
Shares
 
Weighted
Average
Grant
Date Fair
Value
January 1, 2018
 
393,011

 
$
15.64

Granted
 
354,691

 
$
19.09

Vested
 
(113,795
)
 
$
16.36

Forfeited
 
(53,560
)
 
$
17.24

Unvested at September 30, 2018
 
580,347

 
$
17.60

Schedule of share-based compensation expense recorded in the statement of operations
The Company recorded share-based compensation expense in the statement of operations related to incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock units and the ESPP as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2018
 
2017
 
2018
 
2017
Research and development
 
$
4,431

 
$
3,624

 
$
12,109

 
$
11,986

Selling, general and administrative
 
4,511

 
3,544

 
12,664

 
12,096

Total
 
$
8,942

 
$
7,168

 
$
24,773

 
$
24,082